With all due respect, your messages this past week border on soft bash rather than concern for company direction. Nothing has drastically changed in my opinion and you are suggesting some odd company moves such as canceling the Eltoprazine trial and closing the Geneva office? You also don't think MANF will secure a partner until 2016?